Open AccessNeoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma
Author(s) -
Jiangtao Peng,
Xiang Zhang,
Junlong Song,
Liang Ran,
Rong Luo,
Hongyuan Li,
Yonghong Wang
Publication year - 2019
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000013554
Subject(s) - medicine , pirarubicin , epirubicin , docetaxel , immunohistochemistry , estrogen receptor , chemotherapy , oncology , ki 67 , anthracycline , progesterone receptor , invasive ductal carcinoma , cyclophosphamide , gastroenterology , breast cancer , cancer